Document Detail


Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis.
MedLine Citation:
PMID:  10511765     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cefpirome is a fourth-generation cephalosporin with good activity against both gram-positive and gram-negative bacteria. A multicentre trial was performed to study the efficacy and safety of cefpirome 2 g twice daily in the treatment of sepsis. Sixty-three cases were recruited from 10 hospitals from April 1996 to January 1998. Fifty seven cases could be evaluated according to the protocol. The APACHE II score was used to measure severity of illness, with 46.9 per cent of patients having APACHE II score more than 10 and two patients more than 20; both were cured. The most common pathogens were gram-negative bacteria with E. coli predominating 16/40 (40.0%), followed by Klebsiella 8/40 (20.0%). The overall clinical success rates were 54 out of 57 patients (94.7%). In patients with positive blood culture, the clinical cures were achieved for 20/22 (90.9%). Cefpirome showed good efficacy and safety in the empirical treatment of suspected bacteremia or sepsis.
Authors:
P Suwangool; C Suttinont; C Bowonwatanuwong; A Rajanuwong; S A Kulpradist; V Dusitnanond; P Chayakul; P Chetchotisakd; S Leelasupasri; N Aswapokee
Related Documents :
3688315 - Empirical treatment of shigella dysentery with trimethoprim: five-day course vs. single...
11083625 - Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combinatio...
24635455 - Assessment of labor using a new type partogram compared to the classical fisher partogram.
2938995 - A multicentre trial with bacampicillin (penglobe) in the treatment of respiratory tract...
22120685 - Ex vivo study of bevacizumab transport through porcine nasal mucosa.
24676535 - Therapeutic efficacy of vacuum-assisted-closure therapy in the treatment of lymphatic c...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the Medical Association of Thailand = Chotmaihet thangphaet     Volume:  82     ISSN:  0125-2208     ISO Abbreviation:  J Med Assoc Thai     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-10-22     Completed Date:  1999-10-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7507216     Medline TA:  J Med Assoc Thai     Country:  THAILAND    
Other Details:
Languages:  eng     Pagination:  648-53     Citation Subset:  IM    
Affiliation:
Department of Medicine, Faculty of Medicine, Chulalongkorn Hospital, Bangkok, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Bacteremia / drug therapy*,  microbiology
Cephalosporins / administration & dosage*,  adverse effects
Drug Administration Schedule
Female
Follow-Up Studies
Gram-Negative Bacterial Infections / drug therapy*,  microbiology
Gram-Positive Bacterial Infections / drug therapy*,  microbiology
Humans
Male
Middle Aged
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cephalosporins; 84957-29-9/cefpirome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of disseminated Mycobacterium avium complex infection in Thai AIDS patients.
Next Document:  Giardia lamblia in AIDS patients with diarrhea.